Partners
Anteo Diagnostics undertakes collaborative partnerships with diagnostic, research and other life sciences companies where there is a need to improve the performance of assay products and/or achieve better batch reproducibility with less reagent usage. We develop and identify Mix&GoTM formulations that best complement the partners target materials and surfaces, and out-license various components of our technology platform to effectively use such Mix&GoTM formulations.
Mix&GoTM formulations are currently used in certain products from:
Life Technologies, Inc
Bangs Laboratories, Inc
Merck KGaA.
The goal of the partnerships is to allow faster development of new products, provide manufacturing benefits, generate assay enhancements and increase sensitivity. Our initial focus is the clinical diagnostic (pathology) industry, specifically, the in vitro diagnostics markets (nano- and micron-sized bead manufacturers and immunoassay suppliers), Point of Care (POC) markets (membrane manufacturers and POC suppliers), as well as both scientific and clinical research markets (bead, membrane and instrument manufacturers).
Where appropriate, we also actively seek collaborative opportunities in other applications areas that would benefit from the use of Mix&GoTM.
